Mira Pharmaceuticals (MIRA) Free Cash Flow (2022 - 2025)
Mira Pharmaceuticals (MIRA) posted Free Cash Flow of -$1.2 million for Q4 2025, down 4.15% sequentially from -$1.1 million in Q3 2025, and up 34.99% YoY from -$869196.6 in Q4 2024.
Mira Pharmaceuticals (MIRA) Free Cash Flow (2022 - 2025) Analysis & Trends
Mira Pharmaceuticals (MIRA) has 4 years of Free Cash Flow data on file, last reported at -$1.2 million in Q4 2025.
- Quarterly Free Cash Flow rose 34.99% year-over-year to -$1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.7 million (up 15.48% YoY) and the FY2025 annual result came in at -$4.7 million, up 15.48% from the prior year.
- Free Cash Flow fell to -$1.2 million in Q4 2025 per MIRA's latest filing, from -$1.1 million in the prior quarter.
- The five-year high for Free Cash Flow was -$660813.0 in Q2 2023, with the low at -$1.8 million in Q3 2024.
- Average Free Cash Flow over 4 years is -$1.2 million, with a median of -$1.1 million recorded in 2023.
- Year-over-year, Free Cash Flow slumped 74.4% in 2024 and surged 38.84% in 2025.
- Mira Pharmaceuticals' Free Cash Flow stood at -$975436.0 in 2022, then dropped by 6.11% to -$1.0 million in 2023, then tumbled by 74.4% to -$1.8 million in 2024, then soared by 34.99% to -$1.2 million in 2025.
- Business Quant data shows MIRA's Free Cash Flow at -$1.2 million in Q4 2025, -$1.1 million in Q3 2025, and -$800000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 3.01 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 1.47 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 3.56 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 547.00 Mn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 2.93 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 1.48 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 2.43 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 2.18 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | 346.00 Mn |
| 10 | Mira Pharmaceuticals | 22.51 Mn | 11.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.13 Mn |
| Sep 30, 2025 | -1.13 Mn |
| Jun 30, 2025 | -800,000.00 |
| Jun 30, 2025 | -800,000.00 |
| Mar 31, 2025 | -1.60 Mn |
| Mar 31, 2025 | -1.60 Mn |
| Dec 31, 2024 | -1.81 Mn |
| Dec 31, 2024 | -1.81 Mn |
| Sep 30, 2024 | -1.84 Mn |
| Sep 30, 2024 | -1.84 Mn |
| Jun 30, 2024 | -863,929.00 |
| Jun 30, 2024 | -863,929.00 |
| Mar 31, 2024 | -1.05 Mn |
| Mar 31, 2024 | -1.05 Mn |
| Dec 31, 2023 | -1.04 Mn |
| Dec 31, 2023 | -1.04 Mn |
| Sep 30, 2023 | -1.76 Mn |
| Sep 30, 2023 | -1.76 Mn |
| Jun 30, 2023 | -660,813.00 |
| Jun 30, 2023 | -660,813.00 |